New Delhi, Nov 24 (SocialNews.XYZ) Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all approved antibody therapies, a new Lancet study led by an Indian-origin researcher has revealed. The researchers found that.<br /><br />VIEW MORE : https://bit.ly/1breakingnews<br />
